Pain and inflammation in osteoarthritis
Musculoskeletal system
▶BY MOUTH
▶Adult: 200 mg daily in 1–2 divided doses, then
increased if necessary up to 200 mg twice daily,
discontinue if no improvement after 2 weeks on
maximum dose
Pain and inflammation in rheumatoid arthritis
▶BY MOUTH
▶Adult: 100 mg twice daily, then increased if necessary
to 200 mg twice daily, discontinue if no improvement
after 2 weeks on maximum dose
Ankylosing spondylitis
▶BY MOUTH
▶Adult: 200 mg daily in 1–2 divided doses, then
increased if necessary up to 400 mg daily in 1–2 divided
doses, discontinue if no improvement after 2 weeks on
maximum dose
PDF page 1217
DUE TO INTERACTIONS
▶Manufacturer advises reduce dose by half with
concurrent use of fluconazole.
PDF page 1217
Active gastro-intestinal bleeding.
active gastro-intestinal ulceration. cerebrovascular
disease. inflammatory bowel disease. ischaemic heart
disease. mild to severe heart failure. peripheral arterial
disease
PDF page 1217
Allergic disorders. cardiac impairment (NSAIDs
may impair renal function). coagulation defects.
connective-tissue disorders. dehydration (risk of renal
impairment). elderly (risk of serious side-effects and
fatalities). history of cardiac failure. history of gastro-
intestinal disorders. hypertension. left ventricular
dysfunction. oedema. risk factors for cardiovascular
events
PDF page 1217
Contra-indicated in
patients with a history of hypersensitivity to aspirin or any
other NSAID—which includes those in whom attacks of
asthma, angioedema, urticaria or rhinitis have been
Musculoskeletal system
precipitated by aspirin or any other NSAID.
Contra-indicated in patients with sulfonamide
sensitivity.
PDF page 1218